Abstracts - faqs.org

Abstracts

News, opinion and commentary

Search abstracts:
Abstracts » News, opinion and commentary

Complex drug labels bury safety message

Article Abstract:

The Food and Drug Administration is working hard to improve package inserts in drug bottles by making them 'more user-friendly, more informative and more consistent. Critics say that inserts, which are supposed to provide information on the risks and benefits of drugs, makes prescribing complicated and confusing because they are printed in tiny typeface and medical jargon. Even doctors and FDA's expert advisers ignore package insert intructions, which could result in patients becoming sick or dying.

Author: Rubin, Rita
Publisher: USA Today
Publication Name: USA Today
Subject: News, opinion and commentary
ISSN: 0734-7456
Year: 2000
Drugs

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


RU-486 may face FDA limits

Article Abstract:

Abortion rights activists claim the FDA intends to impose major restrictions on 'abortion pill' RU-486 before approving its sales in the US. Paul Blumenthal, medical director of Planned Parenthood of Maryland, says the FDA wants to track the use of RU-486 from the factory to medical offices and then to the patients. On the other hand, National Abortion Federation Dir Vicki Saporta believes few doctors would prescribe the drug because of the numerous restrictions being planned by the FDA.

Author: Rubin, Rita
Publisher: USA Today
Publication Name: USA Today
Subject: News, opinion and commentary
ISSN: 0734-7456
Year: 2000
Pharmaceutical Preparation Manufacturing, Contraceptive Hormones NEC, Hormones, Contraceptives

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


RU-486 met with praise and condemnation

Article Abstract:

The FDA has finally approved on Sep 28, 2000 the abortion pill RU-486. The go signal came after more than four years since the non-profit Population Council, which owns the US rights to the drug, applied for FDA approval in Mar 1996. Danco Laboratories, which has been licensed by the Population Council to distribute and market RU-486 under the name Mifeprex, said that the drug will be available within a month.

Author: Rubin, Rita
Publisher: USA Today
Publication Name: USA Today
Subject: News, opinion and commentary
ISSN: 0734-7456
Year: 2000

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States
Similar abstracts:
  • Abstracts: Net company Terra aims for Hispanic connection. From rags to capitalism. QXL out to corner market on Web auctions
  • Abstracts: In step with Tom Everett Scott. In step with: Jimmy Smits. In step with: John Lithgow
  • Abstracts: House likely to pass sprawling conservation bill. EPA moves to block lawsuit over mercury. River improvements come at cost to wildlife
  • Abstracts: AirTran aims frills at business fliers. Air service faces heat from fliers. CEO of US Airways abruptly resigns
  • Abstracts: Presidential race holds special significance for Microsoft. Gates donation to aid homeless. Turmoil leaves employees restless
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.